[Survival of malignant and paramalignant pleural effusions in Ouagadougou].

[1]  A. Agrawal,et al.  Clinicopathological profile and course of malignant pleural effusion in a tertiary care teaching hospital in western Uttar Pradesh with special reference to lung cancer , 2015, Lung India : official organ of Indian Chest Society.

[2]  G. Cardoso,et al.  Important prognostic factors for survival in patients with malignant pleural effusion , 2015, BMC Pulmonary Medicine.

[3]  Brennan C Kahan,et al.  Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score , 2014, Thorax.

[4]  A. Egan,et al.  Malignant pleural effusion. , 2014, QJM : monthly journal of the Association of Physicians.

[5]  A. Giatromanolaki,et al.  Prognostic Factors in Patients Presenting with Pleural Effusion Revealing Malignancy , 2014, Respiration.

[6]  M. Ried,et al.  The treatment of pleural carcinosis with malignant pleural effusion. , 2013, Deutsches Arzteblatt international.

[7]  G. Colditz,et al.  Treatment of malignant pleural effusion: a cost-effectiveness analysis. , 2012, The Annals of thoracic surgery.

[8]  A. Billé,et al.  What is the best treatment for malignant pleural effusions? , 2011, Interactive cardiovascular and thoracic surgery.

[9]  J. M. Porcel,et al.  Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions , 2011, Lung.

[10]  F. Jatene,et al.  Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status , 2011, Clinics.

[11]  M. Raza.  Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2011 .

[12]  P. Goldstraw,et al.  Prognostic Factors for Survival after Surgical Palliation of Malignant Pleural Effusion , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  R. Holloway,et al.  Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. , 2010, Journal of palliative medicine.

[14]  L. Cellerin,et al.  Pleurésies malignes révélatrices d’un cancer : comparaison des étiologies avec les pleurésies métastatiques d’un cancer connu , 2008 .

[15]  D. Jiménez,et al.  Etiology and prognostic significance of massive pleural effusions. , 2005, Respiratory medicine.

[16]  Nancy Woods,et al.  Cancer and comorbidity , 2000, Cancer.